432 related articles for article (PubMed ID: 27919103)
1. Primary Care-Based Models for the Treatment of Opioid Use Disorder: A Scoping Review.
Korthuis PT; McCarty D; Weimer M; Bougatsos C; Blazina I; Zakher B; Grusing S; Devine B; Chou R
Ann Intern Med; 2017 Feb; 166(4):268-278. PubMed ID: 27919103
[TBL] [Abstract][Full Text] [Related]
2. Test of a workforce development intervention to expand opioid use disorder treatment pharmacotherapy prescribers: protocol for a cluster randomized trial.
Molfenter T; Knudsen HK; Brown R; Jacobson N; Horst J; Van Etten M; Kim JS; Haram E; Collier E; Starr S; Toy A; Madden L
Implement Sci; 2017 Nov; 12(1):135. PubMed ID: 29141653
[TBL] [Abstract][Full Text] [Related]
3. The Washington State Hub and Spoke Model to increase access to medication treatment for opioid use disorders.
Reif S; Brolin MF; Stewart MT; Fuchs TJ; Speaker E; Mazel SB
J Subst Abuse Treat; 2020 Jan; 108():33-39. PubMed ID: 31358328
[TBL] [Abstract][Full Text] [Related]
4. Update on pharmacotherapy for treatment of opioid use disorder.
Ayanga D; Shorter D; Kosten TR
Expert Opin Pharmacother; 2016 Dec; 17(17):2307-2318. PubMed ID: 27734745
[TBL] [Abstract][Full Text] [Related]
5. Implementing Office-Based Opioid Treatment Models in Primary Care.
Brooks EM; Tong S
J Am Board Fam Med; 2020; 33(4):512-520. PubMed ID: 32675262
[TBL] [Abstract][Full Text] [Related]
6. Medications for management of opioid use disorder.
Koehl JL; Zimmerman DE; Bridgeman PJ
Am J Health Syst Pharm; 2019 Jul; 76(15):1097-1103. PubMed ID: 31361869
[TBL] [Abstract][Full Text] [Related]
7. The case for a medication first approach to the treatment of opioid use disorder.
Winograd RP; Presnall N; Stringfellow E; Wood C; Horn P; Duello A; Green L; Rudder T
Am J Drug Alcohol Abuse; 2019; 45(4):333-340. PubMed ID: 31084515
[No Abstract] [Full Text] [Related]
8. Medication-assisted treatment for opioid use disorder within a 12-step based treatment center: Feasibility and initial results.
Klein AA; Seppala MD
J Subst Abuse Treat; 2019 Sep; 104():51-63. PubMed ID: 31370985
[TBL] [Abstract][Full Text] [Related]
9. Medication-Assisted Treatment Considerations for Women with Opiate Addiction Disorders.
Jacobs AA; Cangiano M
Prim Care; 2018 Dec; 45(4):731-742. PubMed ID: 30401353
[TBL] [Abstract][Full Text] [Related]
10. Review of medication-assisted treatment for opioid use disorder.
Ghanem N; Dromgoole D; Hussein A; Jermyn RT
J Osteopath Med; 2022 Mar; 122(7):367-374. PubMed ID: 35285220
[TBL] [Abstract][Full Text] [Related]
11. Treatment of opioid use disorder in primary care.
Buresh M; Stern R; Rastegar D
BMJ; 2021 May; 373():n784. PubMed ID: 34011512
[TBL] [Abstract][Full Text] [Related]
12. Rural access to MAT in Pennsylvania (RAMP): a hybrid implementation study protocol for medication assisted treatment adoption among rural primary care providers.
Cochran G; Cole ES; Warwick J; Donohue JM; Gordon AJ; Gellad WF; Bear T; Kelley D; DiDomenico E; Pringle J
Addict Sci Clin Pract; 2019 Aug; 14(1):25. PubMed ID: 31366408
[TBL] [Abstract][Full Text] [Related]
13. The Role of Primary Care in Improving Access to Medication-Assisted Treatment for Rural Medicaid Enrollees with Opioid Use Disorder.
Cole ES; DiDomenico E; Cochran G; Gordon AJ; Gellad WF; Pringle J; Warwick J; Chang CH; Kim JY; Kmiec J; Kelley D; Donohue JM
J Gen Intern Med; 2019 Jun; 34(6):936-943. PubMed ID: 30887440
[TBL] [Abstract][Full Text] [Related]
14. Age related medication for addiction treatment (MAT) use for opioid use disorder among Medicaid-insured patients in New York.
Neighbors CJ; Choi S; Healy S; Yerneni R; Sun T; Shapoval L
Subst Abuse Treat Prev Policy; 2019 Jun; 14(1):28. PubMed ID: 31238952
[TBL] [Abstract][Full Text] [Related]
15. Documented opioid use disorder and its treatment in primary care patients across six U.S. health systems.
Boudreau DM; Lapham G; Johnson EA; Bobb JF; Matthews AG; McCormack J; Liu D; Campbell CI; Rossom RC; Binswanger IA; Yarborough BJ; Arnsten JH; Cunningham CO; Glass JE; Murphy MT; Zare M; Hechter RC; Ahmedani B; Braciszewski JM; Horigian VE; Szapocznik J; Samet JH; Saxon AJ; Schwartz RP; Bradley KA
J Subst Abuse Treat; 2020 Mar; 112S():41-48. PubMed ID: 32220410
[TBL] [Abstract][Full Text] [Related]
16. Approach to buprenorphine use for opioid withdrawal treatment in the emergency setting.
Cisewski DH; Santos C; Koyfman A; Long B
Am J Emerg Med; 2019 Jan; 37(1):143-150. PubMed ID: 30355476
[TBL] [Abstract][Full Text] [Related]
17. An overview on medication-assisted treatment (MAT) for opioid dependence.
Maiti T; Das S; Ramasamy A; Stanley Xavier A; Kumar Behera S; Selvarajan S
J Opioid Manag; 2020; 16(2):141-149. PubMed ID: 32329889
[TBL] [Abstract][Full Text] [Related]
18. Medication-assisted treatment of opioid use disorder: review of the evidence and future directions.
Connery HS
Harv Rev Psychiatry; 2015; 23(2):63-75. PubMed ID: 25747920
[TBL] [Abstract][Full Text] [Related]
19. Online Medication Assisted Treatment Education for Court Professionals: Need, Opportunities and Challenges.
Matusow H; Rosenblum A; Fong C
Subst Use Misuse; 2021; 56(10):1439-1447. PubMed ID: 34154519
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]